Curasight is a pioneer in the field of exploiting a novel PET imaging target – the urokinase-type plasminogen activator receptor (uPAR) – for improved breast cancer diagnose.

Contact name:

Morten Persson


Ole Maaløes Vej 3, 2200 Copenhagen, Denmark

If you can't find it here or have feedback to our website, please do not hesitate to contact or 28895854

Copyright 2014 Danskbiotek. All rights reserved.